Cargando…
PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING?
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428705/ http://dx.doi.org/10.1097/01.HS9.0000975656.75914.62 |
| _version_ | 1785090533037703168 |
|---|---|
| author | Moura, Pedro Marques, Bárbara Afonso, Carolina Gomes, Rita Duarte, Sara Carda, José Pedro Santos, Catarina Geraldes Guilherme, Raquel |
| author_facet | Moura, Pedro Marques, Bárbara Afonso, Carolina Gomes, Rita Duarte, Sara Carda, José Pedro Santos, Catarina Geraldes Guilherme, Raquel |
| author_sort | Moura, Pedro |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428705 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104287052023-08-17 PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING? Moura, Pedro Marques, Bárbara Afonso, Carolina Gomes, Rita Duarte, Sara Carda, José Pedro Santos, Catarina Geraldes Guilherme, Raquel Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428705/ http://dx.doi.org/10.1097/01.HS9.0000975656.75914.62 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Moura, Pedro Marques, Bárbara Afonso, Carolina Gomes, Rita Duarte, Sara Carda, José Pedro Santos, Catarina Geraldes Guilherme, Raquel PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING? |
| title | PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING? |
| title_full | PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING? |
| title_fullStr | PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING? |
| title_full_unstemmed | PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING? |
| title_short | PB2228: WHAT IS THE UTILITY OF THE MYSEC-PM ON SECONDARY MYELOFIBROSIS RISK STRATIFICATION IN A REAL LIFE SETTING? |
| title_sort | pb2228: what is the utility of the mysec-pm on secondary myelofibrosis risk stratification in a real life setting? |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428705/ http://dx.doi.org/10.1097/01.HS9.0000975656.75914.62 |
| work_keys_str_mv | AT mourapedro pb2228whatistheutilityofthemysecpmonsecondarymyelofibrosisriskstratificationinareallifesetting AT marquesbarbara pb2228whatistheutilityofthemysecpmonsecondarymyelofibrosisriskstratificationinareallifesetting AT afonsocarolina pb2228whatistheutilityofthemysecpmonsecondarymyelofibrosisriskstratificationinareallifesetting AT gomesrita pb2228whatistheutilityofthemysecpmonsecondarymyelofibrosisriskstratificationinareallifesetting AT duartesara pb2228whatistheutilityofthemysecpmonsecondarymyelofibrosisriskstratificationinareallifesetting AT cardajosepedro pb2228whatistheutilityofthemysecpmonsecondarymyelofibrosisriskstratificationinareallifesetting AT santoscatarinageraldes pb2228whatistheutilityofthemysecpmonsecondarymyelofibrosisriskstratificationinareallifesetting AT guilhermeraquel pb2228whatistheutilityofthemysecpmonsecondarymyelofibrosisriskstratificationinareallifesetting |